We are proud to announce that after several years of unsuccessful grant applications, we finally received funds to establish a new and equitable pathway for high school graduates and students who discontinued a STEM program to enter the local STEM …
The MIDD just recently started to collaborate with Simmpyra Pharmaceuticals, a new startup company that is located at the new UWM chemistry building. CEO and cofounder Gunnar Gottschalk and CSO and co-founder Avik Roy are focusing on the development of …
The MIDD has started to work with Sanacor, Inc last summer and is planning to support Sanacor during their journey to develop new therapies to alleviate mitochondrial dysfunction in cardiometabolic diseases. Sanacor co-founder Mike Widlansky and MIDD director Leggy Arnold …